No datasets match
- 1.cvGEE::aidsDidanosine versus Zalcitabine in HIV Patients
- 2.cvGEE::pbc2Mayo Clinic Primary Biliary Cirrhosis Data
- 3.JM::aidsDidanosine versus Zalcitabine in HIV Patients
- 4.JM::aids.idDidanosine versus Zalcitabine in HIV Patients
- 5.JM::pbc2Mayo Clinic Primary Biliary Cirrhosis Data
- 6.JM::pbc2.idMayo Clinic Primary Biliary Cirrhosis Data
- 7.JM::prothroPrednisone versus Placebo in Liver Cirrhosis Patients
- 8.JM::prothrosPrednisone versus Placebo in Liver Cirrhosis Patients
- 9.JMbayes::aidsDidanosine versus Zalcitabine in HIV Patients
- 10.JMbayes::aids.idDidanosine versus Zalcitabine in HIV Patients
- 11.JMbayes::pbc2Mayo Clinic Primary Biliary Cirrhosis Data
- 12.JMbayes::pbc2.idMayo Clinic Primary Biliary Cirrhosis Data
- 13.JMbayes::prothroPrednisone versus Placebo in Liver Cirrhosis Patients
- 14.JMbayes::prothrosPrednisone versus Placebo in Liver Cirrhosis Patients
- 15.JMbayes2::aidsDidanosine versus Zalcitabine in HIV Patients
- 16.JMbayes2::aids.idDidanosine versus Zalcitabine in HIV Patients
- 17.JMbayes2::pbc2Mayo Clinic Primary Biliary Cirrhosis Data
- 18.JMbayes2::pbc2.idMayo Clinic Primary Biliary Cirrhosis Data
- 19.JMbayes2::prothroPrednisone versus Placebo in Liver Cirrhosis Patients
- 20.JMbayes2::prothrosPrednisone versus Placebo in Liver Cirrhosis Patients
- 21.ltm::AbortionAttitude Towards Abortion
- 22.ltm::EnvironmentAttitude to the Environment
- 23.ltm::ghGauss-Hermite Quadrature Points
- 24.ltm::LSATThe Law School Admission Test (LSAT), Section VI
- 25.ltm::MobilityWomen's Mobility
- 26.ltm::ScienceAttitude to Science and Technology
- 27.ltm::WIRSWorkplace Industrial Relation Survey Data